| Literature DB >> 28166391 |
Johann Dion1, Frédérique Deshayes2, Nataliya Storozhylova1, Tamara Advedissian2, Annie Lambert1, Mireille Viguier2, Charles Tellier1, Christophe Dussouy1, Françoise Poirier2, Cyrille Grandjean1.
Abstract
Galectins have been recognized as potential novel therapeutic targets for the numerous fundamental biological processes in which they are involved. Galectins are key players in homeostasis, and as such their expression and function are finely tuned in vivo. Thus, their modes of action are complex and remain largely unexplored, partly because of the lack of dedicated tools. We thus designed galectin inhibitors from a lactosamine core, functionalized at key C2 and C3' positions by aromatic substituents to ensure both high affinity and selectivity, and equipped with a spacer that can be modified on demand to further modulate their physico-chemical properties. As a proof-of-concept, galectin-3 was selectively targeted. The efficacy of the synthesized di-aromatic lactosamine tools was shown in cellular assays to modulate collective epithelial cell migration and to interfere with actin/cortactin localization.Entities:
Keywords: cell migration; drug design; galectin-3; inhibitors; skin tissue repair; wound healing
Mesh:
Substances:
Year: 2017 PMID: 28166391 DOI: 10.1002/cbic.201600673
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164